Curcumin
Curcumin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Multiple Myeloma, Smoldering、Multiple Myeloma、Monoclonal Gammopathy of Undetermined Significance、Interaction。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
2 项
已进入 III/IV 期
12 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Memorial Sloan Kettering Cancer Center
- Washington State University
- Texas Tech University Health Sciences Center
- Tri-Service General Hospital (TSGH)
- Lisa Flowers
- Istanbul University
- University of the Punjab
- Ottawa Hospital Research Institute
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、中国台湾、Turkey (Türkiye)、Pakistan、加拿大、Thailand、Mexico、Egypt、法国、英国、Ethiopia、中国
正在招募患者的 Curcumin 研究
Curcumin and Retinal Study
I 期 / II 期招募中美国NCT05774704Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
不适用招募中中国台湾NCT07241182Safety of Anal Curcumin
I 期招募中美国NCT06626230Effect of Curcumin Topical Spray on Wound Healing After Tooth Extraction
不适用招募中Turkey (Türkiye)NCT07874789Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting
I 期招募中PakistanNCT05610878The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
III 期招募中加拿大NCT04871412The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus
不适用招募中ThailandNCT06932848Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
I 期 / II 期招募中美国NCT05768919Curcumin Supplementation in Cervical Cancer
不适用招募中MexicoNCT06080841A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
不适用招募中美国NCT06055894Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
不适用招募中美国NCT07063056Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment
不适用招募中EgyptNCT07331935Anti-inflammatory Effects of Curcumin, Ginger and Piperine Supplementation in Ultra-trail Runners: a Double-blind Randomized Placebo-controlled Trial
不适用招募中法国NCT07699575A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
不适用招募中美国NCT05640843The Effectiveness of a Herbal Supplement in Osteoarthritis.
不适用招募中英国NCT07324746Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial
不适用招募中EthiopiaNCT05947513Curcumin in Critically Ill Patients With Sepsis
不适用招募中MexicoNCT07436130GynMDD Add-On to Supportive Psychotherapy in Mild to Moderate Depression
不适用招募中法国NCT07416747Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords
I 期 / II 期招募中中国NCT05688488Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
II 期招募中美国NCT06063486Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
早期 I 期招募中美国NCT06531863Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac
早期 I 期招募中美国NCT06053411Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma
I 期招募中加拿大NCT07456605Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
III 期招募中美国NCT03769766
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。